Monday, 31 August 2026European Markets

ATLANTIC SAPPHIRE Stock 11.24% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with ATLANTIC SAPPHIRE (ASA.OL) jumping 11.24% to kr0.80 on Tuesday, following the last session's downward trend. Oslo Børs Benchmark Index_GI fell 0.43% to kr1,404.80, after four sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

ATLANTIC SAPPHIRE's last close was kr0.72, 96.48% under its 52-week high of kr20.36.

About ATLANTIC SAPPHIRE

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-25.71.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -24.26%.

Volume

Today's last reported volume for ATLANTIC SAPPHIRE is 452665 which is 39.53% below its average volume of 748671.

Moving Average

ATLANTIC SAPPHIRE's value is way under its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

More news about ATLANTIC SAPPHIRE (ASA.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com